Qube Research & Technologies Ltd - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 193 filers reported holding BEAM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$3,508,072
+226.0%
114,568
+510.3%
0.02%
+66.7%
Q1 2022$1,076,000
+186.9%
18,773
+335.1%
0.01%
+80.0%
Q3 2021$375,000
+9.0%
4,315
+61.3%
0.01%
+25.0%
Q2 2021$344,000
+7.8%
2,675
-32.9%
0.00%
-20.0%
Q1 2021$319,0003,9860.01%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
HSG Holding Ltd 1,127,934$31,582,0005.60%
Omega Fund Management, LLC 302,821$8,479,0002.32%
Redmile Group, LLC 3,356,958$93,995,0001.74%
BRANDYWINE MANAGERS, LLC 10,875$305,0001.25%
DC Investments Management, LLC 88,100$2,467,0000.91%
Alphabet Inc. 663,691$18,583,0000.86%
Cormorant Asset Management, LP 796,429$22,036,0000.84%
HHLR ADVISORS, LTD. 2,966,403$83,059,0000.76%
Temasek Holdings (Private) Ltd 3,354,641$93,930,0000.56%
Granahan Investment Management 96,598$2,705,0000.10%
View complete list of BEAM THERAPEUTICS INC shareholders